IONS
Ionis Pharmaceuticals Inc
$45.89
0.32 (0.70%) Today
— up— down
Market Cap
$7.63B-28.5%
Revenue (TTM)
$878.11M-7.5%
Net Income (TTM)
$-576,960,342
$-576,960,342EPS (TTM)
-3.47
-3.47Shares Out
166.18M
166.18MOpen
$45.89
$45.89Previous Close
$45.57
$45.57Day Range
$45.39 – $46.46
$45.39 – $46.4652-Week Range
$43.01 – $86.74
$43.01 – $86.74Beta
0.40
0.40Volume
3.71M
3.71MAvg Volume
3.20M
3.20MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout IONS
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015.
Related
News
Alnylam Pharmaceuticals: More Than Meets The Eye After CARDIO-TTRansform
SeekingAlpha · 1d ago
Ionis Pharmaceuticals (IONS) Stock Looks Pricey On Its 45% YTD Slide
Yahoo · 5d ago
Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and Ionis
Yahoo · 5d ago
HC Wainwright & Co. Reiterates Buy on Ionis Pharmaceuticals, Maintains $100 Price Target
Benzinga · 6d ago
Roche, Ionis RNA drug scores in kidney disease study
Yahoo · 6d ago